Epidemiology and Infectious DiseasesEpidemiology and Infectious DiseasesЭпидемиология и инфекционные болезни3034-20073034-2015Eco-Vector4089910.17816/EID40899ArticlesСтатьиResearch ArticleEpidemiological situation with hepatitis C in IranЭпидемиологическая ситуация с гепатитом С в ИранеNikolaevaL. IНиколаеваЛюдмила Ивановна

руководитель лаб. генно-инженерных препаратов, доктор биол. наук. Институт вирусологии им. Д.И. Ивановского при ФГБУ «ФНИЦЭМ им. Н.Ф. Гамалеи»

L.i.nikolaeva@mail.ruBehzadpourD. NБехзадпурДарьюш Насроллах

Rasht branch

отделение Рашт, канд. вет. наук, доцент

dbehzadpour@gmail.comN.F. Gamaleya Federal Research Center of Epidemiology and MicrobiologyФГБУ «Федеральный научно-исследовательский центр им. Н.Ф. Гамалеи» Минздрава РоссииIslamic Azad UniversityИсламский Университет Азада15062015203VOL 20, NO3 (2015)ТОМ 20, №3 (2015)576023072020Copyright ©; 2015, Eco-vectorCopyright ©; 2015, ООО "Эко-вектор"2015Eco-vectorООО "Эко-вектор"https://rjeid.com/1560-9529/article/view/40899

The aim of the review was to present modern data on epidemiology of hepatitis C in Islamic Republic of Iran. In the review there are considered main routs of the infection transmission, groups of high risk and structure of hepatitis C genotypes.

Цель - представить современные данные по эпидемиологии гепатита С в Исламской Республике Иран. В обзоре рассмотрены основные пути передачи инфекции, группы риска и структура генотипов вируса гепатита С.

hepatitis CepidemiologyIranгепатит СэпидемиологияИранAlavian S.-M. We need a new national approach to control hepatitis C: It is becoming too late. Hepatit. Monthly. 2008; 8: 165-9.Brown R.S. Jr., Gaglio P.J. Scope of worldwide hepatitis C problem. Liver transpl. 2003; 9: S10-3.Hajiani E., Masjedizadeh R., Hashemi J., Azmi M., Rajabi T. Hepatis C virus transmission and its risk factors within families of patients infected with hepatitis C virus in southern Iran: Khuzestan. World J Gastroenterol. 2006; 12: 7025-8.Mohd Hanafiah K., Groeger J., Flaxman A.D., Wiersma S.T. Global epidemiology of hepatitis C virus infection: new estimates of agespecific antibody to HC V seroprevalence. Hepatology. 2013; 57: 1333-42.Raja N.S., Janjua K.A. Epidemiology hepatitis C virus infection in Pakistan. J. Microbiol. Immunol. Infect. 2008; 41: 4-8.Smith D.B., Bukh J., Kuiken C., Muerhoff A.S. et al. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology. 2014; 59: 318-27.Всемирная Организация Здравоохранения. Иран (Исламская Республика). http://www.who.int/countries/irn/ru/.Kabir A., Alavian S.-M., Keyvani H. Distribution of hepatitis C virus genotypes in patients inected by different sources and its correlation with clinical and virological parameters: a preliminary study. Comp. Hepatol. 2006; 5: 4-9.Merat S., Rezvan H., Nouraie M., Jafari E., Abolghasemi H., Radmard A.R. et al. Seroprevalence of hepatitis C virus: the first population-based study from Iran. Int. J. Infect. Dis. 2010; 14 (Suppl. 3): e113-6.Alavian S.-M., Adibi P., Zari M.R. Hepatitis C virus in Iran: Epidemiology of an emerging infection. Arch. Iran Med. 2005; 8: 84-90.Эпидемиологическая оценка гепатитов В и С по маркерам инфекционных заболеваний у здорового населения Баку и Нахичевани. Медицинские новости Грузии. 2010; 184-185: 40-4.Khodabandehloo M., Roshani D., Sayehmiri K. Prevalence and trend of hepatitis C virus infection among blood donors in Iran: A systematic review and meta-analysid. J. Res. Med. Sci. 2013; 18: 674-82.Samimi-Rad K., Shahbaz B. Hepatitis C virus genotypes among patients with thalassemia and inherited bleeding disorders in Markazi province, Iran. Haemophilia. 2007; 13: 156-63.Alavian S.-M., Einollani B., Hajarizaden B., Bakhtiari S., Nafar M., Ahrabi S. Prevalence of hepatitis C virus infection and related risk factors among Iranian hemodialysis patients. Nephrology. 2003; 8: 256-60.Zamani S., Ichikawa S., Nassirimanesh B. et al. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran. Int. J. Drug Policy. 2007; 18: 359-63.Farshadpour F., Makvandi M., Samarbafzadeh A.R., Jalalifar M.A. Determination of hepatitis C virus genotypes among blood donors in Ahvaz, Iran. Indian J. Med. Microbiol. 2010; 28: 54-6.Samimi-Rad K., Nategh R., Malekzadeh R., Norder H., Magnius L. Molecular epidemiology of hepatitis C virus in Iran as reflected by phylogenetic analysis of the NS5B region. J. Med. Virol. 2004; 74 (10): 246-52.Waheed Y., Shaft T., Safi S.Z., Qadri I. Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors. World J. Gastroenterol. 2009; 15: 5647-53.Jamalidoust M., Namayandeh M., Assei S., Aliabadi N., Ziyaeyan M. Determining hepatitis C virus genotype distribution among high-risk groups using real-time PCR . World J. Gastroenterol. 2014; 20: 5897-902.Salehi Moghadam F., Mohebbi S.R., Hosseini S.M., et al. Phylogenetic ananlysis of hepatitis C virus strains and risk factors associated with infection and viral subtypes among Iranian patients. J. Med.Virol. 2014; 86: 1342-9.Butt S., Idrees M., Akbar H., ur Rehman I., Awan Z., Afzal S. et al. The changing epidemiology pattern and frequency distribution of hepatitis C virus in Pakistan. Infect. Genet. Evol. 2010; 10: 595-600.Bautista C.T., Todd C.S., Abed A.M.S., Botros B.A., Strathdee S.A., Earhart K.C. et al. Effects of duration of injection drug use and age at first injection on HC V among IDU in Kabul, Afghanistan. J. Publ. Hlth. 2010; 32: 336-41.Rais-Jalali G., Khajehdeni P. Anti-HC V seropositivity among hemodialysis patients of Iranian origin. Nephrol. Dial. Transplant. 1999; 14: 2055-6.Asar M.M., Kooloobandi A. Prevalence of hepatitis C virus infection in thalassemia and hemodialysis patients in North Iran, Rasht. J. Viral Hepatol. 2002; 9: 390-2.Joukar F., Khalesi A.K., Jafarshad R., Rahimabadi M.S., Mansour-Ghanaei F. Distribution of hepatitis C virus genotypes in haemodialysis patients of Guilan, northern Islamic Republic of Iran. East Mediterr. Health J. 2012; 18: 236-40.Alavan S.-M., Kabir A., Ahmadi A.B., Lankarani K.B., Shahbabaie M.A., Ahmadzad-Ast M. Hepatitis C infection in hemodialysis patients in Iran: a systemic review. Hemodial. Int. 2010; 14 (3): 253-62.Samimi-Rad K., Nasiri Toosi M., Masoudi-Nejad A. et al. Molecular epidemiology of hepatitis C virus among injection drug users in Iran: a slight change in prevalence of HC V genotypes over time. Arch. Virol. 2012; 157: 1959-65.Keyvani H., Alizadeh A.H., Alavian S.-M., Ranjbar M., Hatami S. Distribution frequency of hepatitis C virus genotypes in 2231 patients in Iran. Hepatol. Res. 2007; 37: 101-3.Hadinedoushan H., Salmanroghani H., Kazem Amirbaigy M., Akhondi-Meybodi M. Hepatitis C virus genotypes and association with viral load in Yazd, central province of Iran. Hepat. Mon. 2014; 14: e11705.Rastin M., Mahmoudi M., Rezace S.A. et al. Distribution of hepatitis C virus genotypes in city of Mashhad, North-east of Iran. Indian J. Med. Microbiol. 2014; 32: 53-6.Zakesh S.H., Kardi M.T., Edalati M. Hepatitis C virus genotypes frequency in Isfahan province of Iran. Virology J. 2010; 7: 69-74.Vahdat K., Keyvani H., Tabib S.M. et al. Molecular epidemiology of hepatitis C virus genotypes in Bushehr province, Iran. Eur. Rev. Med. Pharmacol. 2010; 14: 861-4.Kabir A., Alavan S.M., Keyvani H. Distribution of hepatitis C virus genotypes in patients infected by different sources and its correlation with clinical and virological parameters: a preliminary study. Comp. Hepatol. 2006; 5: 4.Jahanbakhsh Sefidi F. , Keyvani H., Monavari S.H., Alavian S.M., Fakhim S., Bokharaei-Salim F. Distribution of hepatitis C virus genotypes in Iranian chronic infected patients. Hepat. Mon. 2013; 1: e7991.Salehi Moghadam F., Mohebbi S.R., Hosseini S.M., Mirtalebi H., Romani S., Azimzadeh P. et al. Hepatitis C virus 6a infection in an Iranian patient: a case report. J. Microbiol. 2013; 6: e6560.Alagoz G.K., Karatayli S.C., Karatayli C., Celik E., Keskin E., Dinc B. et al. Hepatitis C virus genotype distribution in Turkey remains unchanged after a decade: Performance of phylogenetic analysis of the NS5B, E1, and 5’UTR regions in genotyping efficiency. Turk. J. Gastroenterol. 2014; 25: 405-10.Львов Д.К., Самохвалов Е.И., Mishiro S., Tsuda F., Селиванов Н.А., Okamoto H. и др. Закономерности распространения вируса гепатита С в России и странах СНГ. Вопросы вирусологии. 1997; 42 (4): 157-61.Самохвалов Е.И., Николаева Л.И., Альховский С.В., Хлопова И.Н., Макашова В.В., Петрова Е.В. и др. Частота встречаемости отдельных субтипов вируса гепатита С в Московском регионе. Вопросы вирусологии. 2013; 58 (1): 36-40.